| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prosaposin receptor activity | 1.38e-06 | 2 | 24 | 2 | GO:0036505 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 1.15e-05 | 37 | 24 | 3 | GO:0000175 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 1.46e-05 | 40 | 24 | 3 | GO:0016896 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 2.09e-05 | 45 | 24 | 3 | GO:0004532 | |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 5.24e-05 | 61 | 24 | 3 | GO:0008408 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.51e-05 | 62 | 24 | 3 | GO:0016796 | |
| GeneOntologyMolecularFunction | poly(A)-specific ribonuclease activity | 1.07e-04 | 13 | 24 | 2 | GO:0004535 | |
| GeneOntologyMolecularFunction | catecholamine binding | 1.07e-04 | 13 | 24 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | exonuclease activity | 1.79e-04 | 92 | 24 | 3 | GO:0004527 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.28e-04 | 133 | 24 | 3 | GO:0008528 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 5.63e-04 | 136 | 24 | 3 | GO:0004540 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 6.13e-04 | 140 | 24 | 3 | GO:0001653 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 8.51e-04 | 36 | 24 | 2 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 8.51e-04 | 36 | 24 | 2 | GO:0015662 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 8.51e-04 | 36 | 24 | 2 | GO:0019865 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.57e-03 | 49 | 24 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.84e-03 | 53 | 24 | 2 | GO:0008188 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.51e-03 | 62 | 24 | 2 | GO:0019829 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.58e-03 | 231 | 24 | 3 | GO:0004518 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 3.54e-03 | 884 | 24 | 5 | GO:0004930 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 4.47e-03 | 1353 | 24 | 6 | GO:0004888 | |
| GeneOntologyMolecularFunction | peptide binding | 6.32e-03 | 318 | 24 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 7.41e-03 | 337 | 24 | 3 | GO:0031625 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 7.53e-03 | 109 | 24 | 2 | GO:0042626 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 7.58e-03 | 664 | 24 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 8.75e-03 | 358 | 24 | 3 | GO:0044389 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 9.21e-03 | 121 | 24 | 2 | GO:1902936 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.04e-02 | 129 | 24 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.32e-02 | 417 | 24 | 3 | GO:0140098 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.39e-02 | 793 | 24 | 4 | GO:0015075 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.41e-02 | 151 | 24 | 2 | GO:0015085 | |
| GeneOntologyBiologicalProcess | negative regulation of protein catabolic process in the vacuole | 1.29e-05 | 5 | 24 | 2 | GO:1904351 | |
| GeneOntologyBiologicalProcess | negative regulation of lysosomal protein catabolic process | 1.29e-05 | 5 | 24 | 2 | GO:1905166 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic mRNA processing body assembly | 1.94e-05 | 6 | 24 | 2 | GO:0010606 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic mRNA processing body assembly | 3.62e-05 | 8 | 24 | 2 | GO:0010603 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 8.50e-05 | 12 | 24 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta production | 8.50e-05 | 12 | 24 | 2 | GO:0071635 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.17e-04 | 14 | 24 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3.09e-04 | 286 | 24 | 4 | GO:0007188 | |
| GeneOntologyBiologicalProcess | P-body assembly | 3.23e-04 | 23 | 24 | 2 | GO:0033962 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 3.53e-04 | 24 | 24 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 4.70e-04 | 132 | 24 | 3 | GO:0000956 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 4.81e-04 | 28 | 24 | 2 | GO:0007039 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 6.70e-04 | 33 | 24 | 2 | GO:0000289 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta production | 8.43e-04 | 37 | 24 | 2 | GO:0071634 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta production | 9.85e-04 | 40 | 24 | 2 | GO:0071604 | |
| GeneOntologyCellularComponent | CCR4-NOT complex | 1.63e-04 | 16 | 25 | 2 | GO:0030014 | |
| GeneOntologyCellularComponent | multivesicular body membrane | 5.85e-04 | 30 | 25 | 2 | GO:0032585 | |
| Domain | GPR37_orph | 1.72e-06 | 2 | 25 | 2 | IPR003909 | |
| Domain | WBP1-like | 1.03e-05 | 4 | 25 | 2 | IPR021684 | |
| Domain | WBP-1 | 1.03e-05 | 4 | 25 | 2 | PF11669 | |
| Domain | P-type_TPase_V | 1.72e-05 | 5 | 25 | 2 | IPR006544 | |
| Domain | Fibrinogen_CS | 2.90e-04 | 19 | 25 | 2 | IPR020837 | |
| Domain | - | 4.66e-04 | 24 | 25 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 4.66e-04 | 24 | 25 | 2 | IPR014715 | |
| Domain | - | 5.48e-04 | 26 | 25 | 2 | 3.60.10.10 | |
| Domain | Exo_endo_phos | 5.48e-04 | 26 | 25 | 2 | PF03372 | |
| Domain | Endo/exonuclease/phosphatase | 5.92e-04 | 27 | 25 | 2 | IPR005135 | |
| Domain | Fibrinogen_C | 5.92e-04 | 27 | 25 | 2 | PF00147 | |
| Domain | FBG | 6.83e-04 | 29 | 25 | 2 | SM00186 | |
| Domain | - | 7.31e-04 | 30 | 25 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 7.31e-04 | 30 | 25 | 2 | IPR014716 | |
| Domain | FIBRINOGEN_C_2 | 8.32e-04 | 32 | 25 | 2 | PS51406 | |
| Domain | Fibrinogen_a/b/g_C_dom | 8.32e-04 | 32 | 25 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_1 | 8.32e-04 | 32 | 25 | 2 | PS00514 | |
| Domain | - | 8.32e-04 | 32 | 25 | 2 | 2.70.150.10 | |
| Domain | - | 8.32e-04 | 32 | 25 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 9.96e-04 | 35 | 25 | 2 | IPR023299 | |
| Domain | ATPASE_E1_E2 | 1.05e-03 | 36 | 25 | 2 | PS00154 | |
| Domain | ATPase_P-typ_P_site | 1.05e-03 | 36 | 25 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 1.05e-03 | 36 | 25 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.11e-03 | 37 | 25 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.11e-03 | 37 | 25 | 2 | PF00122 | |
| Domain | - | 3.30e-03 | 64 | 25 | 2 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 4.98e-03 | 79 | 25 | 2 | IPR023214 | |
| Pathway | KEGG_RNA_DEGRADATION | 4.54e-05 | 59 | 17 | 3 | M963 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.07e-04 | 18 | 17 | 2 | MM15336 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.84e-04 | 21 | 17 | 2 | M27634 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 3.72e-04 | 24 | 17 | 2 | MM15090 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 4.04e-04 | 25 | 17 | 2 | M13492 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 5.51e-04 | 330 | 17 | 4 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 5.70e-04 | 333 | 17 | 4 | MM14963 | |
| Pathway | REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS | 7.07e-04 | 33 | 17 | 2 | M48026 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 7.51e-04 | 34 | 17 | 2 | MM15325 | |
| Pathway | WP_GPCRS_ODORANT | 8.22e-04 | 157 | 17 | 3 | MM15872 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.14e-03 | 176 | 17 | 3 | MM15718 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.15e-03 | 42 | 17 | 2 | MM14971 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.15e-03 | 42 | 17 | 2 | M5868 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.28e-03 | 183 | 17 | 3 | M997 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.34e-03 | 186 | 17 | 3 | MM15994 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.48e-03 | 430 | 17 | 4 | MM15160 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 1.56e-03 | 49 | 17 | 2 | M27614 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 1.89e-03 | 54 | 17 | 2 | MM15089 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.94e-03 | 463 | 17 | 4 | M507 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.96e-03 | 55 | 17 | 2 | M971 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 2.03e-03 | 56 | 17 | 2 | M839 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.10e-03 | 57 | 17 | 2 | MM15643 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.48e-03 | 260 | 17 | 3 | M39397 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.69e-03 | 289 | 17 | 3 | MM15057 | |
| Pathway | WP_GPCRS_OTHER | 5.49e-03 | 93 | 17 | 2 | M39629 | |
| Pathway | WP_GPCRS_OTHER | 5.84e-03 | 96 | 17 | 2 | MM15939 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 5.90e-03 | 314 | 17 | 3 | M600 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 6.45e-03 | 646 | 17 | 4 | MM14962 | |
| Pathway | WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM | 8.01e-03 | 113 | 17 | 2 | M48336 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 8.63e-03 | 702 | 17 | 4 | M746 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 1.02e-02 | 128 | 17 | 2 | M48019 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 34788619 | ||
| Pubmed | GPR37 and GPR37L1 differently interact with dopamine 2 receptors in live cells. | 4.96e-07 | 2 | 25 | 2 | 30423289 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 26848562 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 21233283 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 28688853 | ||
| Pubmed | Mouse Mutants of Gpr37 and Gpr37l1 Receptor Genes: Disease Modeling Applications. | 4.96e-07 | 2 | 25 | 2 | 35457105 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 28642167 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 23690594 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 30926667 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 29407413 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 37075680 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 30478191 | ||
| Pubmed | Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure. | 2.97e-06 | 4 | 25 | 2 | 35385705 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 22977175 | ||
| Pubmed | Characterization of the P5 subfamily of P-type transport ATPases in mice. | 4.95e-06 | 5 | 25 | 2 | 15381061 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 35390160 | ||
| Pubmed | Parkinson disease related ATP13A2 evolved early in animal evolution. | 4.95e-06 | 5 | 25 | 2 | 29505581 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 31924127 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 24749734 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 21078877 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 21741365 | ||
| Pubmed | 2.22e-05 | 10 | 25 | 2 | 27618784 | ||
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 17452450 | ||
| Pubmed | Human Ccr4-Not complexes contain variable deadenylase subunits. | 3.26e-05 | 12 | 25 | 2 | 19558367 | |
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 31320642 | ||
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 34026442 | ||
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 25609427 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 5.18e-05 | 15 | 25 | 2 | 21981923 | |
| Pubmed | RNF219 attenuates global mRNA decay through inhibition of CCR4-NOT complex-mediated deadenylation. | 9.35e-05 | 20 | 25 | 2 | 34887419 | |
| Pubmed | Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. | 1.14e-04 | 22 | 25 | 2 | 18377426 | |
| Pubmed | 3.62e-04 | 39 | 25 | 2 | 23864651 | ||
| Pubmed | 3.98e-04 | 201 | 25 | 3 | 23535732 | ||
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 1.04e-05 | 5 | 19 | 2 | 1213 | |
| GeneFamily | CCR4-NOT transcription complex | 5.72e-05 | 11 | 19 | 2 | 1023 | |
| GeneFamily | Fibrinogen C domain containing | 3.09e-04 | 25 | 19 | 2 | 554 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 3.00e-03 | 78 | 19 | 2 | 262 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.46e-06 | 200 | 25 | 4 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.46e-06 | 200 | 25 | 4 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.59e-05 | 141 | 25 | 3 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.58e-05 | 160 | 25 | 3 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.58e-05 | 160 | 25 | 3 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.58e-05 | 160 | 25 | 3 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | mild-Myeloid-CD14_Monocytes_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.58e-05 | 160 | 25 | 3 | a83568cd8a0b05642bacd43a8ec443e5ce314c4d | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.11e-04 | 168 | 25 | 3 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.15e-04 | 170 | 25 | 3 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.15e-04 | 170 | 25 | 3 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.15e-04 | 170 | 25 | 3 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | Striatum-Macroglia|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.45e-04 | 184 | 25 | 3 | 9ed6a7c7171823b72561db9a6c1de47e82edc4c9 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 25 | 3 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 192 | 25 | 3 | 7bcdbd97fa8c3bfccde426d44979601226913fc3 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.67e-04 | 193 | 25 | 3 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | medial-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 194 | 25 | 3 | 202e5070728191c46161fa7d931f00be1c7559d4 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 194 | 25 | 3 | 04ecb609d233a4b12e275c604810937830363e17 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 194 | 25 | 3 | 002cd317732fc6b0d9a72fb46199f71db5a638a7 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(001)_CD16+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 1.69e-04 | 194 | 25 | 3 | 89cb262e04d7105012e957e0add44c73de6c1ed0 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 194 | 25 | 3 | 775600880bb77781de48085d8744c1030223de1f | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.69e-04 | 194 | 25 | 3 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | (0)_Myeloid-(001)_CD16+_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 1.69e-04 | 194 | 25 | 3 | 4240d0b3cf264f51dcf0cb4d0a18641d85d38638 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 194 | 25 | 3 | ac203d388a3a3884e316dec0dcbd408e43c6ef6c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 194 | 25 | 3 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | Control-Myeloid-CD16_Mono|Control / Disease, Lineage and Cell Type | 1.72e-04 | 195 | 25 | 3 | a37e75be248ff28f6647e4e690629f82c1fb7370 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.72e-04 | 195 | 25 | 3 | 935461e849ca4d17627341b3ae5124d497793a91 | |
| ToppCell | COVID-19_Mild-Non-classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 1.72e-04 | 195 | 25 | 3 | dd00facd20a661ef23fa7fd9a02ee377b8f2d1b9 | |
| ToppCell | IIF-Myeloid-CD16_Mono|IIF / Disease, Lineage and Cell Type | 1.72e-04 | 195 | 25 | 3 | 87c1f52ab19b105bae3f315496c620c226a77a7f | |
| ToppCell | distal-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.72e-04 | 195 | 25 | 3 | 34bed73e4dae34b0f1076b7ff9dc7ea2096c1796 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 1.72e-04 | 195 | 25 | 3 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.72e-04 | 195 | 25 | 3 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | COVID-19_Mild-Non-classical_Monocyte-|COVID-19_Mild / Disease condition and Cell class | 1.72e-04 | 195 | 25 | 3 | 0295d9897830987eec74f51178e14fb0a83723dc | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.72e-04 | 195 | 25 | 3 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | ICU-NoSEP-Myeloid-CD16_Mono|ICU-NoSEP / Disease, Lineage and Cell Type | 1.74e-04 | 196 | 25 | 3 | b15abb1c5396d038bab92b048795020199370f44 | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.74e-04 | 196 | 25 | 3 | 34c1c74cad5e23196e86cfd6f19c836fe57b2264 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.77e-04 | 197 | 25 | 3 | b82142cf8057a55dfa884248b752173661edffd1 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 197 | 25 | 3 | 96d56bce69de7192c7a6b43371b56f4acdcc7733 | |
| ToppCell | Bac-SEP-Myeloid-CD16_Mono|Bac-SEP / Disease, Lineage and Cell Type | 1.77e-04 | 197 | 25 | 3 | c5056605e1a61d165adba9cbee53b7cc0d41ec98 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.77e-04 | 197 | 25 | 3 | 70faaea9c143337a52c8f660ebb063aa92327357 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.77e-04 | 197 | 25 | 3 | 083fec147040ee0bebac2815fb89355cf3a7ffa5 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 197 | 25 | 3 | f0e6745b0fd734ea17e7a2a883e48017e8d3102d | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 197 | 25 | 3 | 422074930fce25a6ad15ba41e391c65787e7878e | |
| ToppCell | myeloid-Monocyte-CD16+_Monocyte|myeloid / Lineage, cell class and subclass | 1.77e-04 | 197 | 25 | 3 | 7ed5dc82ead20406586252ef07164afad8a49994 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|World / Disease group and Cell class | 1.77e-04 | 197 | 25 | 3 | 470784932e1fc3ff69f27cd83f56d85b0c01af63 | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.77e-04 | 197 | 25 | 3 | 368644260f70895052a1d71171a9d882315354dd | |
| ToppCell | COVID-19_Mild-Myeloid-Non-classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 1.77e-04 | 197 | 25 | 3 | 9c943d18f8e6cb0ce9f2158d50796fafae5c81d4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-04 | 197 | 25 | 3 | 5bcf963f21d23edafef1e90dc1de24cd3b0fccce | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-04 | 197 | 25 | 3 | bd7e18a0fed085cfb8ed0e478d1f172a173febbe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-04 | 197 | 25 | 3 | 7e06aee2add54eeff4a9927d9b04b5797160113b | |
| ToppCell | myeloid-Monocyte-CD16+_Monocyte|Monocyte / Lineage, cell class and subclass | 1.80e-04 | 198 | 25 | 3 | a41fa60098e59add84a1687a303c710ab1baa137 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.80e-04 | 198 | 25 | 3 | 8de49c62ab533031936db4cee50ff13b259ecc22 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.80e-04 | 198 | 25 | 3 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 | |
| ToppCell | COVID-19_Convalescent-Non-classical_Monocyte-|COVID-19_Convalescent / Disease condition and Cell class | 1.82e-04 | 199 | 25 | 3 | 996a207b8b91e10dd018dc07aaf5ecd473bfeaad | |
| ToppCell | COVID-19_Convalescent-Non-classical_Monocyte|COVID-19_Convalescent / Disease condition and Cell class | 1.82e-04 | 199 | 25 | 3 | c9250c80dd5bc3d27c6065b99119ff7dcf392e84 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-CD16+_Monocyte|Bac-SEP / Disease, condition lineage and cell class | 1.85e-04 | 200 | 25 | 3 | 4916075ec845733fc4cc1ae61964af7abcf28901 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD16+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | 1.85e-04 | 200 | 25 | 3 | 5c0eb14bdf1bfeaf93f6c3d521529bd5a4de50ce | |
| ToppCell | MS-IIF-Myeloid-CD16+_Monocyte|IIF / Disease, condition lineage and cell class | 1.85e-04 | 200 | 25 | 3 | c6245c24a5e7c550d06a3b2f180773638f9f3a4a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 200 | 25 | 3 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-CD16+_Monocyte|ICU-NoSEP / Disease, condition lineage and cell class | 1.85e-04 | 200 | 25 | 3 | f661e1737be736c62ffb04a45667a65fc3d11e2a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 200 | 25 | 3 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 200 | 25 | 3 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 200 | 25 | 3 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.32e-04 | 55 | 25 | 2 | 21a72cc6f12889509dbfaa9929be48d00f5f6345 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.32e-04 | 55 | 25 | 2 | 6575ee5274f1044e17f4a5204375acc82ef16182 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.45e-04 | 77 | 25 | 2 | ebb1a537751739232820a60f88911877fc683855 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.20e-03 | 92 | 25 | 2 | 926e02725a03d8473eda25d4aef63e34a6566224 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.20e-03 | 92 | 25 | 2 | d2c1d25e5bb6ba4f406e916e3c0a5ad05492e59d | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.42e-03 | 100 | 25 | 2 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.42e-03 | 100 | 25 | 2 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.42e-03 | 100 | 25 | 2 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | COVID-19-kidney-Epithelial_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.03e-03 | 120 | 25 | 2 | e17c85d41c781a29dec7e03a8b0637dccb4346bc | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.13e-03 | 123 | 25 | 2 | 12b87d06e62f142e18424aae5c87454e78e713f0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-03 | 128 | 25 | 2 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.34e-03 | 129 | 25 | 2 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 2.34e-03 | 129 | 25 | 2 | 23b07c71142979d2178fd3a3cdeb3cde73c72c3d | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.34e-03 | 129 | 25 | 2 | 856255fbfc7f95642000cfd7704141b2388f7c5c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.38e-03 | 130 | 25 | 2 | c70fb77324916d220d842a575558a8245c276599 | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 2.38e-03 | 130 | 25 | 2 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.42e-03 | 131 | 25 | 2 | 2ccf679b5035b7b9cdb9a9a660cad90288592187 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-|COVID-19_Mild / Disease condition and Cell class | 2.42e-03 | 131 | 25 | 2 | ae5eb9c013674b36987bf26d4f752dbb374f547b | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.42e-03 | 131 | 25 | 2 | 88b3298110bc2333ffa202a3f41ac0d24e2308c7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 2.53e-03 | 134 | 25 | 2 | da3cb572d0c19932619e51e272c0555e91b482ac | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.64e-03 | 137 | 25 | 2 | 0c82f815c014d01213d23b466043d6e57186dceb | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.64e-03 | 137 | 25 | 2 | a69976938d4e89315ec0be3a332b91ddf3799d65 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue-Cervical_normal_tissue|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.68e-03 | 138 | 25 | 2 | d3d16b043024914475a5e3db0803be0d4678c165 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.68e-03 | 138 | 25 | 2 | c4f6381977d39ad3f7e1e1fa1217a802e8804132 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue-Cervical_normal_tissue-5|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.68e-03 | 138 | 25 | 2 | d1efb4ef05aba89dd46ce698c5ce359fe8ab41c1 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.68e-03 | 138 | 25 | 2 | 3bb5d4c23335866d41e8e99db0676ee5799e5aff | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-03 | 143 | 25 | 2 | 27e06327f96cb72bd111ea6ece6307e5ebb3a146 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-03 | 143 | 25 | 2 | 138033ff447a61a1bc289b21db82151dcc6a4c7e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-03 | 143 | 25 | 2 | 4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.91e-03 | 144 | 25 | 2 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-03 | 144 | 25 | 2 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.99e-03 | 146 | 25 | 2 | 03a6a442f1f6d173a41aeebbfe41ee08853d9585 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.99e-03 | 146 | 25 | 2 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.07e-03 | 148 | 25 | 2 | fc80c02b51cf55a04ce550838ee2f41d8f656f41 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.07e-03 | 148 | 25 | 2 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-03 | 150 | 25 | 2 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.19e-03 | 151 | 25 | 2 | 71841d2001200d1595c85c2b007ee20791a72927 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.19e-03 | 151 | 25 | 2 | 60aced0c1cc6b509b73308d03d58a3c44d712ef4 | |
| Disease | heart disease (implicated_via_orthology) | 4.38e-04 | 38 | 24 | 2 | DOID:114 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 5.61e-04 | 43 | 24 | 2 | DOID:2476 (implicated_via_orthology) | |
| Disease | vascular endothelial function measurement | 2.93e-03 | 99 | 24 | 2 | EFO_0803369 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLCCWYSWLLLFYYN | 6 | Q6QNK2 | |
| VFCVGLWCLDEYWYY | 251 | Q9HD20 | |
| GYWYFRRTWCEVYLA | 76 | P18089 | |
| YRCYGWYNRSPYLWS | 191 | P24071 | |
| EIWRCYWQYLLSYVL | 241 | O14524 | |
| GYLISCVWNCYRYIN | 261 | Q86VI4 | |
| LCSYIVWYCRWIYNF | 256 | Q9H1X3 | |
| WLADHYYWYALCIFL | 251 | Q9NQ11 | |
| LTYDSARLWWYFGCY | 436 | O15354 | |
| ARLWWYFGCYFCLPT | 441 | O15354 | |
| QNARMWWYFGCYFCL | 306 | O60883 | |
| LYSACFWWLFCYAVD | 126 | P51810 | |
| IWGLIQTWYTCTGCY | 221 | Q6ZN54 | |
| CAAFYRGAWWYRNCH | 401 | Q8N539 | |
| RYICWYCWRTFRYPN | 136 | Q9H4Q3 | |
| LYGYCPSWALNWDYR | 206 | Q9ULM6 | |
| RRWWYRCYAYDSNSP | 191 | Q8NHL6 | |
| FCGACIIAYWRYGSW | 106 | Q96K19 | |
| RFCNYCWCWDLEYGY | 551 | Q8TDI8 | |
| LYGYCPSWALNWEYR | 206 | Q96LI5 | |
| YEQCWKYYCLPSGWG | 2511 | Q15413 | |
| LCWVLRYYYQGCASW | 546 | Q9H0D6 | |
| SCAVSYRGAWWYRNC | 4181 | P22105 | |
| YRGAWWYRNCHYANL | 4186 | P22105 | |
| WYLRMLQCYRCRQWF | 206 | Q5T6S3 | |
| GQSQCCNYYYELWWF | 31 | Q9NX94 | |
| ETGCCTYYYELWWFW | 46 | Q96G27 |